Vimta Labs Limited is contract research and testing services provider in India. The Company operates through the Contract Research and Testing Services segment. It is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include drug discovery, development, and drug life cycle management support services; preclinical research and testing services for medical device companies; contract research and testing for agrochemical and specialty chemical companies; food testing and analytical development services to support manufacturers, processors, farmers, and retailers; and environmental regulatory services, such as impact assessments and post project monitoring to various industries, such as power, infrastructure, and others.As of 26 May 2026, Vimta Labs share price is ₹460.05. The stock opened at ₹455.00, compared to its previous close of ₹451.55. During today's trading session, Vimta Labs share price moved in the range of ₹454.20 to ₹463.40, with an average price of ₹458.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹454.20 and a high of ₹463.40. On the performance front, Vimta Labs share price has declined by 25.27% over the last six months and is down 5.90% on a year-on-year basis.
The market capitalization of Vimta Labs is ₹2,138 Crs, with a P/E ratio of 34.8 and a dividend yield of 0.44%.